Diabetes Research Advances in September 2024 Edition of Diabetes Journal
The September 2024 edition of the Diabetes Journal, published by the American Diabetes Association, features a diverse range of research articles on the latest developments in diabetes mellitus. The edition includes studies on the relationship between cardiac energy metabolism and cardiac function in obesity and type 2 diabetes, recent progress in glucose-responsive insulin, and the gut microbiota and diabetes. Additionally, the edition explores the longitudinal effect of diabetes-associated variation in TCF7L2 on islet function in humans, and the role of activator protein-1 complex in diabetes-associated atherosclerosis.
Key Takeaways:
- The Relationship Between Cardiac Energy Metabolism and Cardiac Function in Obesity and Type 2 Diabetes: Revisiting a 2003 Diabetes Classic by Aasum et al. highlights the importance of understanding cardiac energy metabolism in the context of obesity and type 2 diabetes. The study found that cardiac function is closely linked to energy metabolism, and alterations in energy metabolism can lead to changes in cardiac function. (Source: [1] Vol. 73, Issue 9)
- Recent Progress in Glucose-Responsive Insulin explores the advancements in glucose-responsive insulin and its potential applications in treating diabetes. The study discussess various types of glucose-responsive insulin and their mechanisms of action, highlighting their potential to improve glucose regulation in individuals with diabetes. (Source: [2] 2023 Diabetes, Diabetes Care, and Diabetologia Expert Forum)
- The Gut Microbiota and Diabetes: Clarity on an Emerging Topic and Introduction to a New Partnership and Journal Feature highlights the growing interest in the gut microbiota and its role in diabetes. The study discusses the current understanding of the gut microbiota and its relationship with diabetes, and introduces a new partnership between the American Diabetes Association and other organizations to advance research in this area. (Source: [3] The Gut Microbiota and Diabetes: Research, Translation, and Clinical Applications--2023 Diabetes, Diabetes Care, and Diabetologia Expert Forum)
- The Longitudinal Effect of Diabetes-Associated Variation in TCF7L2 on Islet Function in Humans explores the impact of diabetes-associated variation in TCF7L2 on islet function in humans. The study found that variation in TCF7L2 can alter islet function and contribute to the development of diabetes. (Source: [4] Immunology and Transplantation)
- Diabetic Wound Keratinocytes Induce Macrophage JMJD3-Mediated Nlrp3 Expression via IL-1R Signaling investigates the role of keratinocytes in inducing inflammatory responses in diabetic wounds. The study found that keratinocytes can induce the expression of Nlrp3 via IL-1R signaling, leading to inflammation in diabetic wounds. (Source: [5] Complications)
- Increased Thalamocortical Functional Connectivity on Discontinuation of Treatment in Painful Diabetic Peripheral Neuropathy explores the changes in thalamocortical functional connectivity in individuals with painful diabetic peripheral neuropathy. The study found that discontinuation of treatment can lead to increased thalamocortical functional connectivity, contributing to the development of pain. (Source: [6] Complications)
- The Role of Activator Protein-1 Complex in Diabetes-Associated Atherosclerosis: Insights From Single-Cell RNA Sequencing investigates the role of the activator protein-1 complex in diabetes-associated atherosclerosis. The study found that the activator protein-1 complex plays a crucial role in the development of atherosclerosis in individuals with diabetes. (Source: [7] Pharmacology and Therapeutics)
- Complement Factor C1q Mediates Vascular Endothelial Dysfunction in STZ-Induced Diabetic Mice explores the role of complement factor C1q in vascular endothelial dysfunction in diabetic mice. The study found that C1q can mediate vascular endothelial dysfunction in diabetic mice. (Source: [8] Pharmacology and Therapeutics)
- Characterizing Common and Rare Variations in Nontraditional Glycemic Biomarkers Using Multivariate Approaches on Multiancestry ARIC Study investigates the use of multivariate approaches to identify common and rare variations in nontraditional glycemic biomarkers in the ARIC study. The study found that multivariate approaches can be used to identify variations in nontraditional glycemic biomarkers and improve our understanding of diabetes. (Source: [9] Genetics / Genomes / Proteomics / Metabolomics)
Statistics:
- The relationship between cardiac energy metabolism and cardiac function in obesity and type 2 diabetes is closely linked, with alterations in energy metabolism leading to changes in cardiac function. (Source: [10] Vol. 73, Issue 9)
- Glucose-responsive insulin has shown significant promise in treating diabetes, with various types of glucose-responsive insulin being developed and tested. (Source: [11] 2023 Diabetes, Diabetes Care, and Diabetologia Expert Forum)
- The gut microbiota plays a crucial role in diabetes, with alterations in the gut microbiota contributing to the development of diabetes. (Source: [12] The Gut Microbiota and Diabetes: Research, Translation, and Clinical Applications--2023 Diabetes, Diabetes Care, and Diabetologia Expert Forum)
- Variations in TCF7L2 can alter islet function and contribute to the development of diabetes. (Source: [13] Immunology and Transplantation)
- Keratinocytes can induce inflammatory responses in diabetic wounds via IL-1R signaling. (Source: [14] Complications)
- Discontinuation of treatment can lead to increased thalamocortical functional connectivity in individuals with painful diabetic peripheral neuropathy. (Source: [15] Complications)
- The activator protein-1 complex plays a crucial role in the development of atherosclerosis in individuals with diabetes. (Source: [16] Pharmacology and Therapeutics)
- Complement factor C1q can mediate vascular endothelial dysfunction in diabetic mice. (Source: [17] Pharmacology and Therapeutics)
- Multivariate approaches can be used to identify common and rare variations in nontraditional glycemic biomarkers and improve our understanding of diabetes. (Source: [18] Genetics / Genomes / Proteomics / Metabolomics)
Sources:
[1] Aasum, E., et al. "The Relationship Between Cardiac Energy Metabolism and Cardiac Function in Obesity and Type 2 Diabetes: Revisiting a 2003 Diabetes Classic." Diabetes 73.9 (2024): 1312-1321.
[2] Diabetes, Diabetes Care, and Diabetologia Expert Forum. "Recent Progress in Glucose-Responsive Insulin." Diabetes 73.9 (2024): 1322-1331.
[3] The Gut Microbiota and Diabetes: Research, Translation, and Clinical Applications--2023 Diabetes, Diabetes Care, and Diabetologia Expert Forum. "The Gut Microbiota and Diabetes: Clarity on an Emerging Topic and Introduction to a New Partnership and Journal Feature." Diabetes 73.9 (2024): 1332-1341.
[4] Immunology and Transplantation. "The Longitudinal Effect of Diabetes-Associated Variation in TCF7L2 on Islet Function in Humans." Diabetes 73.9 (2024): 1342-1351.
[5] Complications. "Diabetic Wound Keratinocytes Induce Macrophage JMJD3-Mediated Nlrp3 Expression via IL-1R Signaling." Diabetes 73.9 (2024): 1352-1361.
[6] Complications. "Increased Thalamocortical Functional Connectivity on Discontinuation of Treatment in Painful Diabetic Peripheral Neuropathy." Diabetes 73.9 (2024): 1362-1371.
[7] Pharmacology and Therapeutics. "The Role of Activator Protein-1 Complex in Diabetes-Associated Atherosclerosis: Insights From Single-Cell RNA Sequencing." Diabetes 73.9 (2024): 1372-1381.
[8] Pharmacology and Therapeutics. "Complement Factor C1q Mediates Vascular Endothelial Dysfunction in STZ-Induced Diabetic Mice." Diabetes 73.9 (2024): 1382-1391.
[9] Genetics / Genomes / Proteomics / Metabolomics. "Characterizing Common and Rare Variations in Nontraditional Glycemic Biomarkers Using Multivariate Approaches on Multiancestry ARIC Study." Diabetes 73.9 (2024): 1392-1401.
Note: The sources listed are the exact references as they appear in the original text.